Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Seto

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Cardiovascular Pharmacology|August 2, 2007
Rho kinase (ROCK) inhibitorsJames K Liao, Minoru Seto, Kensuke Noma
Journal of the Neurological Sciences|July 12, 2005
Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trialMasato Shibuya, Shunsaku Hirai, Minoru Seto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 9, 2008
Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitorsMamunur Rashid, Shunsuke Tawara, Yoshihiro Fukumoto, et al.
Neurologia Medico-Chirurgica|June 25, 2008
Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance studyYoshio Suzuki, Masato Shibuya, Shin-ichi Satoh, et al.
Brain Research|January 12, 2008
Wide therapeutic time window for Rho-kinase inhibition therapy in ischemic brain damage in a rat cerebral thrombosis modelShin-ichi Satoh, Yoshinori Toshima, Asako Hitomi, et al.
Circulation Research|August 16, 2003
Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contractionSotaro Sakurada, Noriko Takuwa, Naotoshi Sugimoto, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 2, 2004
Inhibition of protein kinase C-mediated contraction by Rho kinase inhibitor fasudil in rabbit aortaErika Shimomura, Mitsuya Shiraishi, Takahiro Iwanaga, et al.
British Journal of Pharmacology|October 29, 2003
Possible role of the protein kinase C/CPI-17 pathway in the augmented contraction of human myometrium after gestationHiroshi Ozaki, Katsuhiko Yasuda, Yoon-Sun Kim, et al.
Stroke|September 6, 2005
Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protectionYoshiyuki Rikitake, Hyung-Hwan Kim, Zhihong Huang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 29, 2002
RhoA- and RhoD-dependent regulatory switch of Galpha subunit signaling by PAR-1 receptors in cellular invasionQuang-Dé Nguyen, Sandrine Faivre, Erik Bruyneel, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Cardiovascular Pharmacology|August 2, 2007
Rho kinase (ROCK) inhibitorsJames K Liao, Minoru Seto, Kensuke Noma
Journal of the Neurological Sciences|July 12, 2005
Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trialMasato Shibuya, Shunsaku Hirai, Minoru Seto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 9, 2008
Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitorsMamunur Rashid, Shunsuke Tawara, Yoshihiro Fukumoto, et al.
Neurologia Medico-Chirurgica|June 25, 2008
Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance studyYoshio Suzuki, Masato Shibuya, Shin-ichi Satoh, et al.
Brain Research|January 12, 2008
Wide therapeutic time window for Rho-kinase inhibition therapy in ischemic brain damage in a rat cerebral thrombosis modelShin-ichi Satoh, Yoshinori Toshima, Asako Hitomi, et al.
Circulation Research|August 16, 2003
Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contractionSotaro Sakurada, Noriko Takuwa, Naotoshi Sugimoto, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 2, 2004
Inhibition of protein kinase C-mediated contraction by Rho kinase inhibitor fasudil in rabbit aortaErika Shimomura, Mitsuya Shiraishi, Takahiro Iwanaga, et al.
British Journal of Pharmacology|October 29, 2003
Possible role of the protein kinase C/CPI-17 pathway in the augmented contraction of human myometrium after gestationHiroshi Ozaki, Katsuhiko Yasuda, Yoon-Sun Kim, et al.
Stroke|September 6, 2005
Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protectionYoshiyuki Rikitake, Hyung-Hwan Kim, Zhihong Huang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 29, 2002
RhoA- and RhoD-dependent regulatory switch of Galpha subunit signaling by PAR-1 receptors in cellular invasionQuang-Dé Nguyen, Sandrine Faivre, Erik Bruyneel, et al.
Pageof 2